Meesho had a good first day as a public company, with its shares climbing as much as 46% from its issue price as investors jumped to grab a piece of the company built around small merchants and value-conscious consumers. image
Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones. image